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1. Introduction 
 As its sulphate ester, dehydroepiandrosterone (DHEA) is the major 
circulating steroid hormone in the young adult primate and is secreted from the cortex 
of the adrenal gland. This circulating dehydroepiandrosterone sulphate (DHEAS) 
serves as pool of the free steroid DHEA, following uptake then desulphation by the 
steroid sulphatase (Sts) enzyme in various tissues (Reed et al. 2005; Miller 2009; 
Hobkirk 1985). Secretion of DHEAS by the adrenal gland shows a characteristic 
pattern over life, suggestive of functional roles, although few have been fully 
elucidated. In this Chapter, we will focus on the possible role of DHEA in learning 
and memory, either as the free steroid or the sulphate ester DHEAS. 
Endocrine production of DHEAS begins with a high output from the fetal 
adrenal and in association with placental uptake, desulphation and further 
metabolism, is the major contributor of maternal estrogens during late pregnancy. 
However, adrenal DHEAS production declines after birth and plasma concentrations 
of DHEAS then remain low in humans until the age of 6-9 years, when they rise at the 
onset of adrenarche. Circulating DHEAS concentrations continue to rise during 
puberty, reaching a peak of around 5 µM during the second decade of life although 
there is variability between individuals and concentrations are generally higher in 
males than in females (Smith et al. 1975; Orentreich et al. 1984; Campbell 2006). A 
slow decline in the production of DHEAS then follows through adulthood, 
culminating in noticeably low plasma concentrations in the elderly (Orentreich et al. 
1984). 
With the above age-related changes in adrenal DHEAS production, there has 
long been an interest in the influence of DHEA on learning and memory. This was 
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reinforced nearly 30 years ago by the discovery that DHEAS and smaller amounts of 
the free steroid DHEA could be detected in adult male rat brain at concentrations 
which did not change upon removal of the adrenal glands and testes (Corpechot et al. 
1981). This led to the concept of neurosteroids: steroids produced within the nervous 
system.  In addition to rodents, the presence of DHEA and DHEAS has been reported 
in the brains of humans (Lacroix et al. 1987; Lanthier and Patwardhan 1986), other 
primates (Robel et al. 1987), amphibians (reviewed in Mensah-Nyagan et al. 2001) 
and avians (Migues et al. 2002; Tsutsui and Yamazaki 1995). Nevertheless and 
ironically in view of the fact that characterization of DHEA in rat brain led to the 
concept of neurosteroids, the synthesis of DHEA in the mammalian central nervous 
system  remains a controversy. In endocrine glands, the CYP17 (17α- 
dehydrogenase/17,20-lyase) enzyme catalyses the production of DHEA from 
pregnenolone via the intermediate 17α-hydroxyprogesterone. This enzyme shows 
little or no activity in brain tissue (Mellon 2007) and adult male rat brain, which 
contains both pregnenolone and DHEA, lacks detectable concentrations of the above 
intermediate (Ebner et al. 2006). Thus, the possibility remains that as in other tissues, 
circulating DHEAS is imported into the brain and desulphated to DHEA. 
Consideration of the role of DHEA and DHEAS in learning and memory is further 
complicated by two factors: 1. that no specific receptor sites have been identified for 
either of these steroids in brain and 2. that apart from desulphation of DHEAS to 
DHEA, little is known at present of their downstream metabolism in brain to potential 
neuroactive steroids. In this Chapter, we will start by reviewing the possible sites of 
action for DHEA and DHEAS in the brain then outline the processes thought to 
underlie learning and memory before discussing how these might be influenced by 
DHEA(S). 
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2. Modes of Action of DHEA(S) in the brain  
Steroid molecules classically bind to intracellular nuclear or cytoplasmic 
receptors to regulate gene expression. As mentioned above, DHEA appears to have no 
such receptor and so effects on transcription would appear to depend on metabolism 
to other steroids, which in peripheral tissues are known to include both androgens and 
estrogens. However, little is known of DHEA(S) metabolism by brain other than 17-
keto reduction to produce free and sulphated androstenediol in vivo (Kishimoto and 
Hoshi 1972). Such metabolism could underlie the androgenic actions of DHEA in 
mouse brain, although some such activity can be detected even after blocking 
metabolism to the more potent androgens testosterone and dihydrotestosterone (see 
Mo et al. 2009). In addition, there are well-documented anti-glucocorticoid actions of 
DHEA, which occur also in the brain (see Maninger et al. 2009) and could involve 
interactions at the receptors for glucocorticoids and/or competition with the metabolic 
activation of these stress hormones (Muller et al. 2006). Whatever the mechanism, 
such actions of DHEA are likely to be of significance for consideration of the effects 
of stress on learning and memory, particularly with age. 
As well as actions mediated probably indirectly through nuclear steroid 
receptors in the brain, DHEA(S) has been shown to have direct effects on neuronal 
membranes, especially at receptors for neurotransmitters. The latter include 
antagonism at type A receptors for the inhibitory amino acid transmitter γ-
aminobutyric acid (GABAA receptors; Majewska et al. 1990; Spivak 1994) and 
enhancement of N-methyl-D-aspartate (NMDA) type receptors for the excitatory 
amino acid glutamate (Compagnone and Mellon 1998; Lhullier et al. 2004). 
DHEA(S) also shows agonism at type 1 sigma (σ1) receptors (Urani et al. 1998) 
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which underlie further interactions at NMDA and acetylcholine receptors in the brain 
(Monnet et al. 1995; Matsuno et al. 1994; also see review by Monnet and Maurice 
2006). Overall, the above actions on the neuronal membrane could be considered as 
excitatory. However, their relevance to any physiological influences of DHEA(S) on 
learning and memory must be approached with caution as such actions are reported at 
concentrations of these steroids higher than those observed in brain tissue in vivo.     
     Drugs such as barbiturates and benzodiazepines which are agonists and/or 
enhance the action of GABA at GABAA receptors are associated with impairment of 
memory acquisition Thus it might be expected that the GABAA antagonistic action of 
DHEA(S) would enhance learning (Chapouthier and Venault 2002; Castellano and 
McGaugh 1990). Likewise, the ability of DHEA(S) to enhance postsynaptic NMDA 
receptor function will increase the influx of Ca
2+
 ions, a form of signalling associated 
with the phenomenon of long-term potentiation of synaptic transmission and thought 
to underlie memory formation.  
We will return to the above putative sites of action for DHEA(S) later in this 
Chapter but first give a brief overview of current concepts and experimental 
approaches to learning and memory. 
 
3. Learning and Memory 
Learning is typically understood as the process by which new information or 
knowledge is acquired, while memory is the process by which organisms store, retain 
and recall information. Memory formation is processed in three stages: acquisition 
(the initial phase in formation of a memory trace), consolidation (the phase during 
which the stabilisation of memory trace takes place) and retrieval (the “actualisation” 
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of the memory trace). Once formed, memory can last from minutes to years, 
suggesting the existence of complex mechanisms for altering patterns of neuronal 
connectivity involving changes in gene expression, protein synthesis and ultimately 
cellular structure. 
Memory is often classified according to its endurance into short-term and 
long-term memory. Short-term memory has a limited capacity and allows recall for a 
period of several seconds to a minute without rehearsal. In contrast, long-term 
memory can store much larger quantities of information for a very long time, 
sometimes for a whole life span. However, research on different animal models and 
on humans indicates that long-term memory could be divided into at least two major 
types of memory systems: memory of “how” also called procedural (or implicit) 
memory, and memory of “that” also called declarative (or explicit) memory. Thus, we 
learn in two fundamentally different ways: we learn about the world around us 
acquiring knowledge of people and places and we learn how to do things, acquiring 
different skills. Procedural memory is not based on conscious recall of information in 
contrast to declarative memory, which requires conscious recall (Squire 1986; Squire 
2004; Tulving 1985). According to information type carried, each one of these 
categories could be further subdivided into different subtypes, as shown in Fig 1.  
(Insert Fig 1 here) 
 
Why do we need model systems and different tasks to study memory? 
Because only by using different models and different tasks we might ultimately learn 
how different aspects of behaviour emerge from biological correlates of neural cell 
functions. 
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Standard laboratory tasks used in most memory laboratories today may be 
aversive or appetitive, single or multiple trial. They include passive avoidance and 
fear conditioning (both single trial) and versions of the Morris water maze to test 
spatial memory (multiple trials). All of them might be used to study short-term and 
long-term memory, declarative as well as non-declarative (procedural). The merit of 
one trial tasks is that they are sharply timed; the brevity of the training trial allows for 
a separation of events surrounding the training experience from the processes that 
occur during memory consolidation. However, during passive avoidance training and 
fear conditioning animals could acquire both declarative memories and procedural 
memories. Because procedural memories takes many more trials to acquire than 
declarative memories, measuring retention latencies after one-trial passive avoidance 
training most likely reflects declarative fear memories. Nevertheless, single trial 
learning is not typical of learning in general, because many instances of animal and 
human learning are based on the acquisition of experience in a number of repeated 
trials, involving processes such as generalisation, categorisation and discrimination. 
Our laboratory has a long-standing experience in using the chick as a model 
system to study memory. The training task that we employ is one-trial passive 
avoidance task, in which chicks learn to avoid pecking at a small bead coated in the 
bitter, distasteful but non-toxic methylanthranilate (MeA). The task has the merits of 
being rapid and sharply timed (for a review see Rose 2000). Chicks that are trained to 
peck a bead typically coated with 100% MeA (strong training) show a disgust 
reaction (backing away, shaking their heads and wiping their bills) and will avoid a 
similar but dry bead for at least 48 hours. Another version of the task exists, where the 
bead is coated in 10% MeA (weak training) and chicks show avoidance for up to 8 h 
subsequently. Because the pecking response requires a positive, accurate act by the 
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bird, it also controls for effects on attentional, visual and motor processes. In its 
strong form the task can be used to identify the molecular cascade involved in 
memory formation and the interventions that impair consolidation; in its weak form 
the task can be used to explore potential memory enhancing agents. 
 Because of their closer evolutionary relatedness to humans, mammals are 
usually preferred to birds as model systems. However, the bird brain is not a primitive 
form of the mammalian brain, and has striking homologies and analogies with that of 
the mammal. Interestingly, birds have cognitive capacities that were thought to be the 
characteristic of primates. For example, sensory learning in songbirds shares 
important features with forms of sensory imprinting described in mammals and, 
similarly to mammals, results in a long-lasting and perhaps permanent memory (for 
review see Bolhuis and Gahrb 2004; Reiner et al. 2004). 
The biological mechanisms that underlie learning, memory storage and 
eventually change in behaviour involve a cascade of molecular events such as 
intercellular communication, intercellular messenger systems, cell adhesion 
molecules, growth factors, and gene expression. In chicks, the combination of 
interventive and correlative studies has revealed a cascade of molecular processes 
occurring in defined brain regions, notably the left intermediate medial mesopallium 
(IMMP) and medial striatum. Briefly, within minutes of pecking at the bitter bead, 
there is: 1. enhanced glutamate release, 2. up-regulation of NMDA-sensitive 
glutamate receptors, and 3. the opening of N-type conotoxin-sensitive calcium 
channels. These transient synaptic responses result in the activation of protein kinases 
and the expression of immediate early genes such as c-fos and c-jun and 
subsequently, the family of late genes coding for glycoproteins which, inserted into 
the pre- and post-synaptic membranes, alter synaptic structure and connectivity.
 
In 
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other words, the early phase of memory or short-term memory, depend on transient 
synaptic changes. Without activating transcription of new genes in the nucleus, short-
term memories will quickly fade. The progression from short-term to long-term 
memory, a stable form of memory that can last from hours to life-time, requires the 
mobilisation of molecular processes that go beyond the synapse, to the neuronal 
nucleus, with activation of gene expression and protein synthesis to modify 
permanently synaptic structure.  
 
4. Actions of DHEA(S) on Learning and Memory 
4.1 Animal studies 
 The role of the steroid DHEA and its sulphate ester on learning and memory 
has been studied in animal models by using various learning paradigms. The first 
observations to suggest that DHEA and its sulphate ester may have memory 
enhancing properties in experimental animals were reported by Flood and colleagues. 
In a study using the T-maze footshock active avoidance test, immediate post-training 
intracerebroventricular (i.c.v.) injections of DHEA or DHEAS were found to facilitate 
memory retention one week later in adult male mice (Roberts et al. 1987; see Fig 2)). 
This improved retention was also seen after addition of DHEAS to the drinking water 
(Flood et al. 1988). A great deal of work has followed focusing on the 
physiological/pathological role of DHEA(S) in learning and memory processes and 
investigating their mechanisms of action. To examine their role during the acquisition, 
consolidation and retrieval stages of memory processing, these steroids have been 
administrated at various times throughout the learning process, as outlined below. 
(Insert Fig 2 near here) 
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4.1.1 DHEA(S) pre-training 
 Subcutaneous (s.c.) administration of DHEAS to male mice 60 minutes before 
training on a passive avoidance task enhanced memory retention tested 24 hours later 
with a maximal effect at a dose of 1 mg/kg (Reddy and Kulkarni 1998a; Fig 3A).  
(Insert Fig 3 here) 
 
Additionally, DHEAS has been administered to both male and female adult 
rats trained on the elevated plus-maze test, where decreased transfer latency (the time 
taken by the rat to move into one of the enclosed arms) between training and 24 hours 
delay retention testing was used as a measure of learning and memory.  DHEAS was 
shown to have a memory enhancing effect when administered 30 minutes prior to 
training at 5 mg/kg s.c., with testing done 24 hours later. Interestingly, the memory 
facilitating effects in this study were observed in male but not in female rats, 
demonstrating a sex-specific effect (Reddy and Kulkarni 1999). Another study has 
reported memory enhancement following DHEA administration (28 mg/kg, 
intraperitoneal (i.p.)) to male rats 30 minutes before training on the step-down 
inhibitory avoidance task, with testing carried out at both 1.5 hours and 24 hours later 
(Lhullier et al. 2004). 
 The memory enhancing effects of DHEA and DHEAS have also been 
examined in one-day old chicks using the one-trial passive avoidance-learning 
paradigm which, as mentioned above, has the advantage of a sharply-timed training 
event. Following direct injection 15 minutes before training into the IMMP, a brain 
region known to be specifically involved in the early stages of memory formation in 
these animals (see Rose 2000), both DHEA and DHEAS facilitated memory retention 
in male and female chicks tested 24 hours later. The DHEAS appeared more potent 
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than DHEA, with significant effects seen at minimum doses of 0.04 and 0.3 ng/chick, 
respectively. With the microinjection procedure employed, such doses would have 
resulted in concentrations at the site of injection of 22 µM for DHEAS and 208 μM 
for DHEA, before diffusion into the brain tissue (Migues et al. 2002). Also in chicks, 
a similar enhancement of memory retention tested 24 hours later was seen when 
DHEAS was administered at 20 mg/kg i.p. 30 minutes before training (Sujkovic et al. 
2007; Fig 4A). Use of radioactively labeled DHEAS allowed an estimate of the 
amount of the i.p. dose reaching the brain and assuming a uniform distribution with 
no metabolism of the label, gave an estimated local concentration of around 0.5µM. 
The latter study also found the memory enhancing effect of DHEAS only to be 
significant in males and not females, as reported above for rats. 
(Insert Fig 4 here) 
 
4.1.2 DHEA(S) post-training 
Several studies have examined the effects of DHEA and DHEAS on the 
consolidation of memory, by administering these steroids after training.  
As already mentioned, an early study using the T-maze footshock active 
avoidance paradigm in adult male mice, showed immediate post-training i.c.v. 
injections of DHEA or DHEAS to facilitate memory retention one week later 
(Roberts et al. 1987; Flood et al. 1988). The same authors showed DHEAS also to 
enhance memory retention when administered i.c.v. at 30 and 60 minutes post-
training, but not at 90 or 120 minutes. The most effective doses of DHEA and 
DHEAS would have resulted in local i.c.v. concentrations of around 20 mM, although 
these are likely quickly to have diluted on diffusion into the brain tissue. 
Enhancement of memory retention was also seen following systemic administration 
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of DHEAS to mice trained on the same task; the most effective doses being 20 mg/kg 
s.c. immediately after training or 43 mg/kg/day for one week in the drinking water 
(Flood et al. 1988). Other authors have shown DHEAS to facilitate memory retention 
for a passive avoidance task in male mice when injected s.c. 60 minutes post-training 
and tested 24 hours later, with the most effective dose being 1 mg/kg (Reddy and 
Kulkarni 1998a; Fig 3B).  
In one-day old chicks trained on the one-trial passive avoidance memory task, 
post-training administration of DHEA (3 ng) or DHEAS (4 ng) into the IMMP could 
enhance memory retention when administered at 30 and 60 minutes post-training but 
not at 180 minutes (Migues et al. 2002). Similarly, i.p. administration of DHEAS 
20mg/kg has been shown to enhance memory retention at 30 minutes and 4.5 hours 
post-training in male one-day old chicks trained on the above taste avoidance learning 
paradigm (Sujkovic et al. 2007; Fig 4B and C). In the latter study, as for DHEAS 
administered pre-training, effects were only significant in male and not in female 
chicks. 
 
4.1.3 DHEA(S) pre-testing  
Effects of DHEA and DHEAS on the recall of learning have been addressed 
by administering these steroids prior to recall of a learnt experience and have 
consistently failed to show significant effects on this aspect of memory function. 
Thus, DHEAS administered at 0.125 to 10 mg/kg, s.c. at 1 hour pre-retention test for 
the step-down passive avoidance task in mice had no effects on recall (Reddy and 
Kulkarni 1998a, Fig 3C). Likewise, Maurice et al. 1998 have reported that 
administration of DHEAS (20 mg/kg, s.c.) to mice 30 minutes prior to testing on the 
step-down type of passive avoidance task could not facilitate memory retention 14 
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days post-training. We have also been unable to detect changes in memory 
performance following administration of DHEAS 20 mg/kg i.p. 30 minutes before 
testing to one-day old chicks trained on the one-trial passive avoidance task (Sujkovic 
et al. 2007; Fig 4D). 
 
4.1.4 Anti-amnesic effects  
A number of studies have examined whether DHEA(S) could prevent and/or 
reverse pharmacological impairment of memory. Again, these show effects of 
DHEA(S) on acquisition and consolidation, rather than recall of memory. 
 Using the T-maze footshock active avoidance paradigm, Flood et al. (1988), 
reported anti-amnesic effects of DHEAS. In this study, 15 minutes prior to training, 
mice were administered with anisomycin (ANI) (20 mg/kg, s.c.), an inhibitor of 
protein synthesis, followed by immediate post-training injections of DHEAS (162 ng, 
i.c.v.) and an additional ANI injection at 1.75 hours later. Here, DHEAS was shown 
to reverse the amnesic effects of ANI when tested at one week post-training. It 
therefore appears that DHEAS may influence the process of protein synthesis that 
accompanies consolidation of memory. This is consistent with our observation that 
DHEAS enhances memory in the one-day old chick if administered at 30 minutes or 
4.5 hours post-training (Sujkovic et al. 2007). These time points have been shown 
previously to be accompanied by protein synthesis which is crucial for the formation 
of memory in the chick model system (reviewed Rose 2000).  
Using the same behavioural paradigm (Flood et al. 1988) have also studied 
whether DHEAS could reverse memory impairment induced by the muscarinic 
cholinergic receptor antagonist, scopolamine (SCO). Here, the learning deficit 
induced by SCO (1 mg/kg, s.c.) injected immediately after training could be reversed 
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by subsequent injection with DHEAS (162 ng, i.c.v.) at 45 minutes post-training. By 
contrast, DHEA (0.300, 1.350, 6.075 g/kg) has failed to reverse a SCO (1 mg/kg) 
induced amnesia when administrated to mice trained on a spontaneous alternation 
task, a measure of short-term memory formation (Bazin et al. 2009). 
 Both DHEA and DHEAS could block ethanol induced memory impairment in 
male mice trained on win-shift foraging paradigm. In this study, steroids were 
injected at the dose of 0.05 mg/kg, i.p. 30 minutes prior to the testing trial, whilst 
ethanol was injected at 0.5 g/kg, i.p. at 10 minutes pre-testing (Melchior and 
Ritzmann 1996). Given that ethanol induced memory impairment can be potentiated 
by GABAA agonists such as muscimol but inhibited by its antagonists such as 
picrotoxin and bicuculline (Castellano and Pavone 1988), the observed effects of 
steroids in this study are consistent with their interactions with the GABAA receptor 
complex. 
 In another study, DHEAS at the doses of 5 and 10 mg/kg s.c. injected at 30 
minutes prior to training could prevent the amnesic effects of the NMDA receptor 
antagonist dizocilpine (0.1 mg/kg, i.p.) administered at 15 minutes pre-training to 
mice trained on both the step-down passive avoidance and elevated plus maze tasks 
(Reddy and Kulkarni 1998b).  
 The possible interactions of DHEA and DHEAS with σ1 receptors are further 
supported by two studies (Maurice et al., 1998; Reddy and Kulkarni 1998a) showing 
the memory enhancing effects of both these steroids given s.c. to be blocked in mice 
when co-administered with the σ1 receptor antagonist haloperidol.  
Indeed, the σ1 receptor may be a necessary target for anti-amnesic compounds 
because the reversal of dizocilpine-induced amnesia by PRE-084 (a selective σ1 
receptor agonist) and by DHEAS in mice trained on spontaneous alternation and 
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passive avoidance task could be blocked by a 16-mer oligodeoxynucleotide antisense 
to the σ1 receptor cDNA which induced down-regulation of σ1 receptor expression in 
the brain (Maurice et al. 2001).  
The above abilities of DHEA and DHEAS to reverse pharmacologically-
induced amnesia are fully consistent with the sites of action for these steroids on 
neurotransmitter receptors described in Section 2. 
 
4.1.5 Steroids and aging 
Other animal studies have addressed the possibility that DHEAS can also 
ameliorate age-related impairments in learning and memory. 
 Flood and Roberts (1988), tested the effects of immediate post-training 
injection of DHEAS (20 mg/kg, s.c.) to middle-aged (18 months old) and old (24 
months old) mice trained on the aversive T-maze footshock active avoidance task. 
Single treatment with DHEAS in this study was found to result in memory 
enhancement in both old and middle-aged animals when tested one week or one 
month after training, respectively. 
 Additionally, the effects of DHEAS have been examined on the impaired 
memory of 16 month as compared with 3 month old mice. When given before training 
on the step-down passive avoidance and elevated plus maze tasks, a dose of 10 mg/kg 
s.c. DHEAS significantly attenuated the age impairment of memory (Reddy and 
Kulkarni 1998b).  
In another study, the effects of DHEAS on working memory as measured on 
the win-shift water escape task have been studied in 18-20 months old male and 
female mice. Here, post-training administration of DHEAS orally for 1 week, in the 
drinking water at the dose of 1.5 mg/mouse/day resulted in memory enhancement, 
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compared to mice given water alone, in both males and females (Markowski et al. 
2001). 
Using aged SAMP8 mice (a model to study amyloid beta toxicity, which is 
thought to be linked with Alzheimer’s disease), one study has reported improved 
learning and memory when DHEAS was administered in drinking water (0.3 mg/mL) 
for 8 weeks to animals trained on the T-maze footshock avoidance paradigm (Farr et 
al. 2004). 
 
4.1.5 Conclusions from animal studies 
 From the evidence of animal studies reviewed here, both DHEA and DHEAS 
are more likely to facilitate memory when administered pre-training and post-training 
but not pre-testing. Thus both these steroids appear to enhance the acquisition and 
consolidation but not the retrieval stages of memory. The sulphated steroid DHEAS is 
more potent in this respect than the free steroid DHEA, at least when a reliable 
comparison of their potencies can be made by direct injection into the chick brain 
(Migues et al. 2002). One possibility is that this higher potency of DHEAS arises at 
least in part from its slower clearance than DHEA from chick brain, as reported by 
Sujkovic et al. 2009 (see Fig 5). The latter study showed desulphation of a small 
proportion of the DHEAS injected into the brain to yield free DHEA during the 
period of memory formation and consolidation in the chick. Similar comparisons of 
the potencies of DHEAS and DHEA following i.c.v. injections in mice cannot be 
made as the studies reviewed here used different solvent vehicles and assessed the 
memory enhancing potencies of the free and sulphated steroids against different 
strengths of training. Nevertheless, several studies in rats and mice have shown 
inhibition of the Sts enzyme to increase the potency of DHEAS to enhance memory 
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and reverse drug-induced amnesia (see Johnson et al. 2000). Such effects should be 
interpreted with caution because these Sts inhibitors have been given peripherally, 
where they will inhibit desulphation of DHEAS in the liver (see Johnson et al. 2000) 
and are also sulphate esters themselves, competing with circulating DHEAS for 
access into the brain (Nicolas and Fry 2007). 
(Insert Fig 5 here) 
 
As for whether or not DHEA and DHEAS require further metabolism in order 
to induce memory enhancing effects, the evidence from reversal of 
pharmacologically-induced amnesia in animals is consistent with the actions of these 
native steroids at the neurotransmitter receptor sites identified in vitro.  Also, our 
study of the metabolism of DHEA and DHEAS after direct injection into chick brain 
showed no detectable conversion to other steroids, at least during the time taken for 
the early stages of memory formation (Sujkovic et al. 2009). However, the animal 
studies described here have used intracerebral doses of DHEA(S) likely to produce 
localized concentrations of these steroids in at least the µM range and over 1000 fold 
higher than the endogenous brain concentrations (see Migues et al. 2002; Sujkovic et 
al. 2007; Ebner et al. 2006).  Moreover, the other studies in which animals were 
administered DHEA(S) peripherally, frequently showed bell-shaped dose-response 
curves, suggesting an optimum dose beyond which additional actions become 
detrimental to learning and memory. More laboratory investigations are required into 
the actions and brain metabolism of DHEAS(S) at physiological concentrations. 
Inevitably, these will be limited by the low adrenal production of DHEA(S) in rodents 
and other laboratory animals in comparison to primates (see Cutler et al. 1978). 
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4.2 Human studies 
 Unsurprisingly, given the above evidence for the enhancement of learning and 
memory in animals by DHEA(S) and the well-known rise in the circulating 
concentrations of these steroids before puberty in humans, followed by a decline 
through adulthood, they have received attention not only as a markers for healthy 
cognitive development and ageing but also as potential treatments to enhance 
performance.  Although some associations have been reported between plasma 
DHEAS and general mental health and performance in the elderly, there appear to be 
no significant correlations with more precise cognitive measures and DHEAS has no 
predictive value for future performance (see Wolf and  Kirschbaum 1999; Vallée et 
al. 2001).  Rigorous assessment of the clinical potential of DHEA(S) to enhance 
cognition, requires controlled investigations of DHEA supplementation of middle-
aged or elderly subjects without dementia. A Cochrane Collaboration review of the 
literature to March 2008 could include only five such studies, with no evidence of a 
beneficial effect of DHEA supplementation on cognition (Grimley Evans et al. 2009).  
However, one study found that oral DHEA supplementation of elderly men and 
women for two weeks, sufficient to elevate their plasma DHEAS concentrations to 
young adult levels, protected against stress-induced deterioration in a test of attention 
(selecting target shapes on a sheet of paper; Wolf et al. 1998; see Fig 6).  This is 
interesting in view of the anti-glucocorticoid effects of DHEA mentioned earlier, 
although the same study found DHEA supplementation to exacerbate the effects of 
stress on declarative memory (visual-verbal memory), possibly by enhancing cortisol 
release. Unlike DHEA(S), adrenal production of cortisol does not show marked age-
related changes. This means that compared to healthy young adults with peak 
DHEA(S) production, children and the elderly have cortisol/DHEA(S) ratios 4-5 
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times higher in both blood and cerebrospinal fluid and so would be expected to be 
especially pre-disposed to the deleterious effects of stress on learning and memory 
(see Herbert 1998).  Supplementation of elderly subjects for 3 months with DHEA 
sufficient to reduce the cortisol/DHEA ratio (as assessed in saliva) did indeed reduce 
confusion, anxiety and mood but had no significant effect on cognition, as measured 
in tests of speed, attention and episodic memory (van Niekerk et al. 2001). 
(Insert Fig 6 here) 
 
5. Concluding remarks 
 Studies in laboratory animals have consistently shown an enhancement of the 
acquisition and consolidation, rather than the recall, of memory by DHEA(S). Perhaps 
this gives some clue to the lack of clear effects in elderly human subjects, where 
recall of life skills and events might be expected to assume a greater importance. 
Nevertheless, controlled studies of learning and memory (of new information) in 
elderly human subjects have shown no significant effects of DHEA(S) 
supplementation. The ability of DHEA(S) to enhance the acquisition and 
consolidation of memory in laboratory animals is greater in males than in females. 
This may reflect actions mediated after conversion of the DHEA(S) to estrogens, 
which should already be higher in the females with functioning ovarian cycles. By the 
same logic and reverting to human subjects, DHEA(S) supplementation would be 
expected to have clearer effects in elderly, post-menopausal women than men. We 
suggest this because although both groups will have declining adrenal DHEA(S) 
production, men should still receive a contribution of these steroids from the testes 
(see Labrie 2010). Supplementation of healthy elderly subjects with DHEA was 
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indeed reported to improve mood in women rather than men (Wolf et al. 1997) but, as 
in other studies, there were no convincing improvements in cognitive performance. 
 So why have clear actions of DHEA(S) on learning and memory in laboratory 
animals not been followed by equally convincing studies in humans? There are 
probably several answers to this question including at least the following: 1. the age-
related changes in DHEA(S) will vary between individuals 2. circulating DHEA(S) 
will fall more rapidly with age in women than men 3. supplementation may occur too 
late in the decline of DHEA(S) with ageing 4. supplementation is usually with oral 
DHEA which can elevate plasma DHEAS but is likely also to produce other steroid 
metabolites 5. the effects of DHEA(S) on cognition will vary according to the levels 
of the stress hormone cortisol and 5. there could be more than one mode of action for 
DHEA(S) and/or its metabolites. 
  In our view, more animal studies are required to elucidate the metabolism and 
mode of action of DHEA(S) in the brain. Such studies can be expected to inform 
clinical investigations of human subjects, which need to be sufficiently powered to 
uncover significant effects through the variables listed above.    
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Summary Points 
 DHEA(S) enhance the acquisition and consolidation stages of memory in 
animal models of memory. 
 DHEA(S) can reverse pharmacologically-induced amnesia in animal models. 
 DHEA(S) does not appear to enhance recall in animal models of memory. 
 DHEA(S) may play a role in age dependent cognitive decline. 
 DHEA(S) supplementation has not yet been convincingly shown to enhance 
learning and memory in normal human ageing.  
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FIGURES
 
 
 
FIGURE 1 Taxonomy of memory: the multiplicity of memory systems and brain 
regions involved. 
 
 
FIGURE 2 Effects of intracerebroventricularly injected DHEA and DHEAS on 
memory retention in mice. (a) DHEA and DMSO in well-trained animals: five 
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training trials in the T maze; the buzzer, loud; intertrial interval, 45 seconds; 
footshock level 0.35 mA. (b) DHEAS in saline in poorly trained animals; four 
training trials : buzzer, muffled; intertrial interval, 30 seconds; footshock level, 
0.30 mA. Injections of test solutions were made within 3 minutes after training. 
Retention was tested 1 week after the training trials. (Reprinted from Roberts, E., 
L. Bologa, J.F. Flood, and G.E. Smith. 1987. Brain Res 406(1-2):357-62. Copyright 
(1987), with permission from Elsevier.) 
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FIGURE 3 The effect of dehydroepiandrosterone sulphate (DHEAS); 0.125-10 
mg/kg) administered subcutaneously to mice (a) 60 minutes before 
(pretraining), (b) immediately after (post-training) the training session or (c) 60 
minutes before the retention test. The training was for passive avoidance of an 
electric shock to the feet, as tested by the step-down latency (left panel) and the 
number of mistakes (right panel). The retention test was performed 24 hours 
after the training session. The results are shown as mean ± standard error of the 
mean with six to eight animals per group. Values marked * or ** were 
significantly different from those obtained with mice injected with the solvent 
vehicle (VEH, 0.1% Tween 80 in saline) alone. (Reprinted from Reddy, D.S., and 
S.K. Kulkarni. 1998a. Brain Res 791(1-2):108-16. Copyright (1998), with 
permission from Elsevier.) 
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FIGURE 4 The effect of DHEAS (20 mg/kg) or saline administered i.p. either (a) 
30 minutes before training, (b) post-training at 30 minutes, or (c) 4.5 hours or 
(d) 30 minutes before pretesting on recall for the weak aversive stimulus (WS) of 
10% methylanthranilate (MeA). Non-injected controls were trained with the 
strong stimulus (SS) of 100% MeA. Recall was tested 24 hours after training and 
the results presented as percent avoidance. A statistically significant difference 
was observed when percent avoidance was compared between (*) SS group and 
saline injected WS chicks or between (*) DHEAS-injected WS group and saline 
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alone, also before WS. Numbers of animals in each group are presented in the 
relevant bars. (Reprinted from Sujkovic, E., R. Mileusnic, J.P. Fry and S.P. Rose. 
2007. Neuroscience 148(2):375-84. Copyright (2007), with permission from 
Elsevier.) 
 
    
 
 
 
 
 
 
 
FIGURE 5 Typical chromatographic profile (a) from thin layer chromatography 
(TLC) of steroid sulphate fraction extracted from chick brain at 5 minutes after 
an intracranial injection of 3H-dehydroepindrosterone sulphate (DHEAS) to the 
intermediate medial mesopallium and (b) phosphorimage of TLC for steroid 
sulphate fractions at: (1) 5 minutes, (2) 10 minutes, (3) 30 minutes, (4) 1 hour, 
and (5) 5 hours after injection of this label. The peak for DHEAS is labelled. 
(Reprinted from Sujkovic, E., R. Mileusnic, and J.P. Fry. 2009. J Neurochem 
109(2):348-59. Copyright (2009), with permission from John Wiley and Sons.)  
 
DHEAS 
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FIGURE 6 Effects of DHEA and stress on human performance in an attention test. 
Performance (using parallel versions) was tested before and after stress. The 
symbol * indicates a significant difference between pre- and post-stress 
performance for subjects given placebo and the symbol § a significant difference 
between DHEA and placebo. (Reprinted from Wolf, O.T., B.M. Kudielka, D.H. 
Hellhammer, J. Hellhammer, and C. Kirschbaum. 1998. Psychoneuroendocrinology 
23(6):617-29. Copyright (1998), with permission from Elsevier.) 
